BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions

101Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

Abstract

Several bacterial pathogens have TIR domain-containing proteins that contribute to their pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88. BtpB is a novel Brucella effector that is translocated into host cells and interferes with activation of dendritic cells. In vivo mouse studies revealed that BtpB is contributing to virulence and control of local inflammatory responses with relevance in the establishment of chronic brucellosis. Together, our results show that BtpB is a novel Brucella effector that plays a major role in the modulation of host innate immune response during infection.© 2013 Salcedo, Marchesini, Degos, Terwagne, Von Bargen, Lepidi, Herrmann, Santos Lacerda, Imbert, Pierre, Alexopoulou, Letesson, Comerci and Gorvel.

Cite

CITATION STYLE

APA

Salcedo, S. P., Marchesini, M. I., Degos, C., Terwagne, M., Bargen, K. V., Lepidi, H., … Gorvel, J. P. (2013). BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions. Frontiers in Cellular and Infection Microbiology, 4(JUL). https://doi.org/10.3389/fcimb.2013.00028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free